Related Experiment Video
Updated: Aug 20, 2026

A Model of Cardiac Remodeling Through Constriction of the Abdominal Aorta in Rats
Published on: December 2, 2016
Hypothalamic antihypertensive effect of irbesartan in chronic aortic coarctated rats
Christian Höcht1, Javier A W Opezzo, Carlos A Taira
1Department of Pharmacology, Faculty of Pharmacy and Biochemistry, University of Buenos Aires, Buenos Aires, Argentina. chocht@ffyb.uba.ar
Insights
Chronic aortic coarctation in rats did not alter irbesartan pharmacokinetics but enhanced its central nervous system distribution. This suggests a hypothalamic mechanism contributing to irbesartan's greater antihypertensive effect in coarctated animals.
Area of Science:
- Pharmacology
- Cardiovascular Physiology
- Neuroscience
Background:
- Hypertension is a complex condition with multifactorial origins.
- The renin-angiotensin system plays a crucial role in blood pressure regulation.
- Central nervous system mechanisms, particularly within the hypothalamus, are implicated in hypertension management.
Purpose of the Study:
- To investigate the central and plasma pharmacokinetics of irbesartan (IRB) in rats with chronic aortic coarctation (ACo) versus sham-operated (SO) controls.
- To evaluate the potential antihypertensive effect of irbesartan within the hypothalamus.
- To explore the role of central mechanisms in irbesartan's hypotensive action in a hypertensive model.
Main Methods:
- Microdialysis technique was employed to measure irbesartan concentrations in plasma and the anterior hypothalamus.
- Wistar rats underwent either aortic coarctation (ACo) or sham-operation (SO) and were studied at a chronic hypertensive stage.
- Systemic and direct hypothalamic perfusion of irbesartan were performed to assess its effects on heart rate and mean arterial pressure.
Main Results:
- Systemic irbesartan administration caused a greater reduction in mean arterial pressure in ACo rats compared to SO rats.
- Plasma pharmacokinetics of irbesartan were similar between ACo and SO groups.
- Hypothalamic distribution of irbesartan was significantly higher in ACo rats than in SO rats.
- Direct hypothalamic perfusion of irbesartan induced an antihypertensive effect specifically in ACo rats.
Conclusions:
- Chronic aortic coarctation does not alter irbesartan plasma pharmacokinetics but enhances its distribution into the central nervous system.
- The augmented hypotensive effect of irbesartan in coarctated rats suggests the involvement of central mechanisms, potentially via the anterior hypothalamic angiotensin system.
- AT1 receptors in the hypothalamus may play a role in maintaining the hypertensive state in chronic aortic coarctation.
Abstract:
The aim of the present work was to study the central and plasma pharmacokinetics of irbesartan (IRB) and its possible hypothalamic antihypertensive effect in sham-operated (SO) and aortic-coarctated (ACo) rats at a chronic hypertensive stage using the microdialysis technique. Anesthetized Wistar rats were used 42 days after ACo or SO. For the study of plasma pharmacokinetics, a vascular shunt probe was inserted into the carotid artery. In a separated experiment, a concentric probe was placed into the anterior hypothalamus for the study of IRB distribution in the central nervous system. Based on the hypothalamic concentrations of IRB reached in ACo rats, the anterior hypothalamus of SO and ACo animals was perfused with a Ringer solution containing approximately 6 microg x ml(-1) of the drug. IRB (10 mg x kg(-1) i.v.) induced a late decrease of heart rate (HR) in ACo animals (DeltaHR: -42 +/- 10 bpm, n = 5, p < 0.05 vs. SO rats) but not in SO rats (DeltaHR: 11 +/- 13 bpm, n = 5). Systemic administration of the drug reduced the mean arterial pressure (MAP) of both experimental groups, but the hypotensive effect was greater in ACo (DeltaMAP: -39.9 +/- 5.0 mm Hg, n = 5, p < 0.05 vs. SO rats) than in SO rats (DeltaMAP: -25.4 +/- 2.1 mm Hg, n = 5). A similar pharmacokinetic profile was observed in both experimental groups. Hypothalamic distribution of IRB was greater in ACo (AUC: 730 +/- 130 ng x ml(-1) h(-1), n = 5, p < 0.05 vs. SO rats) than in SO animals (AUC: 283 +/- 87 ng x ml(-1) h(-1), n = 5). The IRB hypothalamic perfusion induced an antihypertensive effect in ACo (DeltaMAP: -15.1 +/- 1.0 mm Hg, n = 5, p < 0.05 vs. Ringer perfusion) but not in SO rats. In conclusion, the chronic aortic coarctation did not modify the plasma pharmacokinetics of IRB, but it increased the distribution of the drug in the central nervous system. The greater hypotensive effect of IRB observed in ACo animals suggests the involvement of AT1 receptors in the maintenance of the hypertensive stage in chronic ACo rats. The hypotensive effect of IRB in ACo animals could be explained, at least in part, due an action on the anterior hypothalamic angiotensin system.
Related Concept Videos
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Drugs: Direct Renin Inhibitors
Antihypertensive Drugs: Action of β1 Blockers
